Welcome to the ELOQUENT 1
Multiple Myeloma Study Website

Multiple myeloma is a cancer of the plasma cell, a type of white blood cell present in your bone marrow. Plasma cells are a very important part of the immune system, as they make proteins called antibodies to help you fight infections. This global clinical research program sponsored by Bristol-Myers Squibb (BMS) includes two clinical research studies that will help researchers to learn more about an investigational study drug for patients with multiple myeloma.

If you or someone you know has multiple myeloma, we invite you to learn more about the program and see if there is a participating clinical site near you.

Click here to learn more about the program
Click here to visit the study sponsor's Patient and Caregiver Clinical Study website, Bristol-Myers Squibb Study Connect